Brief: Athenex Announces European Commission Approval Of Klisyri® (Tirbanibulin) For The Topical Treatment Of Actinic Keratosis
July 19 (Reuters) - Athenex Inc ATNX.O :
* ATHENEX ANNOUNCES EUROPEAN COMMISSION APPROVAL OF KLISYRI®
(TIRBANIBULIN) FOR THE TOPICAL TREATMENT OF ACTINIC KERATOSIS
Source text for Eikon: ID:nGNX60BBgh
Further company coverage: ATNX.O
((Reuters.Briefs@thomsonreuters.com;))